Improved Formulation of <sup>224</sup>Ra-Labeled Calcium Carbonate Microparticles by Surface Layer Encapsulation and Addition of EDTMP
Radium-224-labeled CaCO<sub>3</sub> microparticles have been developed to treat peritoneal carcinomatosis. The microparticles function as carriers of <sup>224</sup>Ra, facilitating intraperitoneal retention of the alpha-emitting radionuclide. It was necessary to control the s...
Main Authors: | Ruth Gong Li, Kim Lindland, Sandra Karen Tonstad, Tina Bjørnlund Bønsdorff, Asta Juzeniene, Sara Westrøm, Roy Hartvig Larsen |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/13/5/634 |
Similar Items
-
A Critical Review of Alpha Radionuclide Therapy—How to Deal with Recoiling Daughters?
by: Robin M. de Kruijff, et al.
Published: (2015-06-01) -
Synthesis and Biological Evaluation of <sup>99m</sup>Tc(I) Tricarbonyl Complexes Dual-Targeted at Tumoral Mitochondria
by: Diogo Figueiredo, et al.
Published: (2021-01-01) -
The potential and hurdles of Targeted Alpha Therapy - Clinical trials and beyond
by: Jorgen eElgqvist, et al.
Published: (2014-01-01) -
What is the role of the bystander response in radionuclide therapies?
by: Darren eBrady, et al.
Published: (2013-08-01) -
Dosimetric impact of Ac-227 in accelerator-produced Ac-225 for alpha-emitter radiopharmaceutical therapy of patients with hematological malignancies: a pharmacokinetic modeling analysis
by: George Sgouros, et al.
Published: (2021-08-01)